The Ongoing Fight Against Acute GvHD

EP. 1: Multidisciplinary Approach & First-Line Treatment Options

ByJohn DiPersio, MD, PhD

November 6th 2020

EP. 2: Second-Line Treatment Decision Factors

ByJohn DiPersio, MD, PhD

November 6th 2020

EP. 3: Phase III REACH2 Trial: Recent Data Updates

ByJohn DiPersio, MD, PhD

November 6th 2020

EP. 4: REACH2 Trial Limitations

ByJohn DiPersio, MD, PhD

November 6th 2020

EP. 5: REACH2 Trial Regimen Adverse-Event Profile

ByJohn DiPersio, MD, PhD

November 6th 2020

EP. 6: Practical Advice: GVHD Management With REACH2 Regimen

ByJohn DiPersio, MD, PhD

November 6th 2020

EP. 7: Future of GVHD Management: Promising Clinical Trials

ByJohn DiPersio, MD, PhD

November 6th 2020